Peptide record

TPDB18745

Antibacterial Toxicity standard
28 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB18745
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia
standard
No
A 28-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
EEQRFLPVVAGLAAKVLPSIICAVTKKC
Physicochemical Analysis
C135H231N35O36S2
NDHMWY
AV
2984.65
9.08
4
2
14
+2
5.27
0.729
125.36
Mammalian: 1 hour Yeast: 30 min E.coli: >10 hour
125
4.19
5
Residue Composition
number
4
A
1
R
0
N
0
D
2
C
2
E
1
Q
1
G
0
H
2
I
3
L
3
K
0
M
1
F
2
P
1
S
1
T
0
W
0
Y
4
V
Amino Acid Distribution
A: 4 R: 1 N: 0 D: 0 C: 2 E: 2 Q: 1 G: 1 H: 0 I: 2 L: 3 K: 3 M: 0 F: 1 P: 2 S: 1 T: 1 W: 0 Y: 0 V: 4
Chemical Descriptors
28
C135H231N35O36S2
2984.65
9.08
+2
5.27
0.729
Evidence Records 4 records
Evidence 1 Activity

Activity

MIC
Antibacterial
64 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 64 ug/ml), S.enteritidis (MIC >128 ug/ml), and S. aureus ATCC 29213 (MIC 64-128 ug/ml).
Evidence 2 Activity

Activity

MIC
Antibacterial
>128 µg/mL

Target

S.enteritidis

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 64 ug/ml), S.enteritidis (MIC >128 ug/ml), and S. aureus ATCC 29213 (MIC 64-128 ug/ml).
Evidence 3 Activity

Activity

MIC
Antibacterial
64-128 µg/mL

Target

Staphylococcus aureus ATCC 29213

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 64 ug/ml), S.enteritidis (MIC >128 ug/ml), and S. aureus ATCC 29213 (MIC 64-128 ug/ml).
Evidence 4 Activity

Activity

50% Hemolysis
Toxicity
>128 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | >128 | µg/mL | target cell: Pig erythrocytes

Target

Pig erythrocytes

Source & Reference

NA
DBAASP
Associating Biological Activity and Predicted Structure of Antimicrobial Peptides from Amphibians and Insects. | Antibiotics (Basel) | 2022